The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Drug Eluting Implant Market Research Report 2025

Global Drug Eluting Implant Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1944573

No of Pages : 101

Ask Your Query

Synopsis

Drug eluting implants encompass a wide range of bioactive implants that can be placed in or near a tissue to provide a controlled, sustained or on demand release of drug while overcoming barriers associated with traditional oral and intravenous drug administration, such as limited bioavailability, metabolism, and toxicity.

The global Drug Eluting Implant market was valued at US$ 6855 million in 2023 and is anticipated to reach US$ 10480 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drug Eluting Implant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Implant.

Report Scope

The Drug Eluting Implant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Eluting Implant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Eluting Implant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Boston Scientific
  • Medtronic
  • Abbott
  • Lepu Medical
  • B. Braun Melsungen
  • MicroPort Scientific
  • Cook Medical
  • Terumo
  • Biosensors International
  • Balton
  • AlviMedica Medical Technologies
  • Biotronik
  • Shandong JW Medical
  • Sino Medical
  • Beijing AMSINO

Segment by Type

  • Rapamycin Eluting Implant
  • Paclitaxel Eluting Implant
  • Everolimus Eluting Implant
  • Others

Segment by Application

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Implant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Implant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Drug Eluting Implant Market Overview
1.1 Product Overview and Scope of Drug Eluting Implant
1.2 Drug Eluting Implant Segment by Type
1.2.1 Global Drug Eluting Implant Market Value Comparison by Type (2024-2030)
1.2.2 Rapamycin Eluting Implant
1.2.3 Paclitaxel Eluting Implant
1.2.4 Everolimus Eluting Implant
1.2.5 Others
1.3 Drug Eluting Implant Segment by Application
1.3.1 Global Drug Eluting Implant Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Drug Eluting Implant Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Implant Revenue 2019-2030
1.4.2 Global Drug Eluting Implant Sales 2019-2030
1.4.3 Global Drug Eluting Implant Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Eluting Implant Market Competition by Manufacturers
2.1 Global Drug Eluting Implant Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Eluting Implant Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Eluting Implant Average Price by Manufacturers (2019-2024)
2.4 Global Drug Eluting Implant Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Implant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Implant, Product Type & Application
2.7 Drug Eluting Implant Market Competitive Situation and Trends
2.7.1 Drug Eluting Implant Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Eluting Implant Players Market Share by Revenue
2.7.3 Global Drug Eluting Implant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Eluting Implant Retrospective Market Scenario by Region
3.1 Global Drug Eluting Implant Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Eluting Implant Global Drug Eluting Implant Sales by Region: 2019-2030
3.2.1 Global Drug Eluting Implant Sales by Region: 2019-2024
3.2.2 Global Drug Eluting Implant Sales by Region: 2025-2030
3.3 Global Drug Eluting Implant Global Drug Eluting Implant Revenue by Region: 2019-2030
3.3.1 Global Drug Eluting Implant Revenue by Region: 2019-2024
3.3.2 Global Drug Eluting Implant Revenue by Region: 2025-2030
3.4 North America Drug Eluting Implant Market Facts & Figures by Country
3.4.1 North America Drug Eluting Implant Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Eluting Implant Sales by Country (2019-2030)
3.4.3 North America Drug Eluting Implant Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Implant Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Implant Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Eluting Implant Sales by Country (2019-2030)
3.5.3 Europe Drug Eluting Implant Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Implant Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Eluting Implant Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Eluting Implant Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug Eluting Implant Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug Eluting Implant Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Implant Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Eluting Implant Sales by Country (2019-2030)
3.7.3 Latin America Drug Eluting Implant Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Implant Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Implant Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Eluting Implant Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Eluting Implant Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Implant Sales by Type (2019-2030)
4.1.1 Global Drug Eluting Implant Sales by Type (2019-2024)
4.1.2 Global Drug Eluting Implant Sales by Type (2025-2030)
4.1.3 Global Drug Eluting Implant Sales Market Share by Type (2019-2030)
4.2 Global Drug Eluting Implant Revenue by Type (2019-2030)
4.2.1 Global Drug Eluting Implant Revenue by Type (2019-2024)
4.2.2 Global Drug Eluting Implant Revenue by Type (2025-2030)
4.2.3 Global Drug Eluting Implant Revenue Market Share by Type (2019-2030)
4.3 Global Drug Eluting Implant Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Eluting Implant Sales by Application (2019-2030)
5.1.1 Global Drug Eluting Implant Sales by Application (2019-2024)
5.1.2 Global Drug Eluting Implant Sales by Application (2025-2030)
5.1.3 Global Drug Eluting Implant Sales Market Share by Application (2019-2030)
5.2 Global Drug Eluting Implant Revenue by Application (2019-2030)
5.2.1 Global Drug Eluting Implant Revenue by Application (2019-2024)
5.2.2 Global Drug Eluting Implant Revenue by Application (2025-2030)
5.2.3 Global Drug Eluting Implant Revenue Market Share by Application (2019-2030)
5.3 Global Drug Eluting Implant Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Drug Eluting Implant Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Drug Eluting Implant Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Drug Eluting Implant Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Corporation Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lepu Medical Drug Eluting Implant Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 B. Braun Melsungen
6.5.1 B. Braun Melsungen Corporation Information
6.5.2 B. Braun Melsungen Description and Business Overview
6.5.3 B. Braun Melsungen Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B. Braun Melsungen Drug Eluting Implant Product Portfolio
6.5.5 B. Braun Melsungen Recent Developments/Updates
6.6 MicroPort Scientific
6.6.1 MicroPort Scientific Corporation Information
6.6.2 MicroPort Scientific Description and Business Overview
6.6.3 MicroPort Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MicroPort Scientific Drug Eluting Implant Product Portfolio
6.6.5 MicroPort Scientific Recent Developments/Updates
6.7 Cook Medical
6.6.1 Cook Medical Corporation Information
6.6.2 Cook Medical Description and Business Overview
6.6.3 Cook Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cook Medical Drug Eluting Implant Product Portfolio
6.7.5 Cook Medical Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Corporation Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Terumo Drug Eluting Implant Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 Biosensors International
6.9.1 Biosensors International Corporation Information
6.9.2 Biosensors International Description and Business Overview
6.9.3 Biosensors International Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biosensors International Drug Eluting Implant Product Portfolio
6.9.5 Biosensors International Recent Developments/Updates
6.10 Balton
6.10.1 Balton Corporation Information
6.10.2 Balton Description and Business Overview
6.10.3 Balton Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Balton Drug Eluting Implant Product Portfolio
6.10.5 Balton Recent Developments/Updates
6.11 AlviMedica Medical Technologies
6.11.1 AlviMedica Medical Technologies Corporation Information
6.11.2 AlviMedica Medical Technologies Drug Eluting Implant Description and Business Overview
6.11.3 AlviMedica Medical Technologies Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.11.4 AlviMedica Medical Technologies Drug Eluting Implant Product Portfolio
6.11.5 AlviMedica Medical Technologies Recent Developments/Updates
6.12 Biotronik
6.12.1 Biotronik Corporation Information
6.12.2 Biotronik Drug Eluting Implant Description and Business Overview
6.12.3 Biotronik Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Biotronik Drug Eluting Implant Product Portfolio
6.12.5 Biotronik Recent Developments/Updates
6.13 Shandong JW Medical
6.13.1 Shandong JW Medical Corporation Information
6.13.2 Shandong JW Medical Drug Eluting Implant Description and Business Overview
6.13.3 Shandong JW Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shandong JW Medical Drug Eluting Implant Product Portfolio
6.13.5 Shandong JW Medical Recent Developments/Updates
6.14 Sino Medical
6.14.1 Sino Medical Corporation Information
6.14.2 Sino Medical Drug Eluting Implant Description and Business Overview
6.14.3 Sino Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sino Medical Drug Eluting Implant Product Portfolio
6.14.5 Sino Medical Recent Developments/Updates
6.15 Beijing AMSINO
6.15.1 Beijing AMSINO Corporation Information
6.15.2 Beijing AMSINO Drug Eluting Implant Description and Business Overview
6.15.3 Beijing AMSINO Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Beijing AMSINO Drug Eluting Implant Product Portfolio
6.15.5 Beijing AMSINO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Implant Industry Chain Analysis
7.2 Drug Eluting Implant Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Implant Production Mode & Process
7.4 Drug Eluting Implant Sales and Marketing
7.4.1 Drug Eluting Implant Sales Channels
7.4.2 Drug Eluting Implant Distributors
7.5 Drug Eluting Implant Customers
8 Drug Eluting Implant Market Dynamics
8.1 Drug Eluting Implant Industry Trends
8.2 Drug Eluting Implant Market Drivers
8.3 Drug Eluting Implant Market Challenges
8.4 Drug Eluting Implant Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Drug Eluting Implant Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Drug Eluting Implant Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Drug Eluting Implant Market Competitive Situation by Manufacturers in 2023
Table 4. Global Drug Eluting Implant Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Drug Eluting Implant Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Drug Eluting Implant Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Drug Eluting Implant Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Drug Eluting Implant Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Drug Eluting Implant, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drug Eluting Implant, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drug Eluting Implant, Product Type & Application
Table 12. Global Key Manufacturers of Drug Eluting Implant, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Eluting Implant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Implant as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Eluting Implant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Drug Eluting Implant Sales by Region (2019-2024) & (K Units)
Table 18. Global Drug Eluting Implant Sales Market Share by Region (2019-2024)
Table 19. Global Drug Eluting Implant Sales by Region (2025-2030) & (K Units)
Table 20. Global Drug Eluting Implant Sales Market Share by Region (2025-2030)
Table 21. Global Drug Eluting Implant Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Drug Eluting Implant Revenue Market Share by Region (2019-2024)
Table 23. Global Drug Eluting Implant Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Drug Eluting Implant Revenue Market Share by Region (2025-2030)
Table 25. North America Drug Eluting Implant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Drug Eluting Implant Sales by Country (2019-2024) & (K Units)
Table 27. North America Drug Eluting Implant Sales by Country (2025-2030) & (K Units)
Table 28. North America Drug Eluting Implant Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Drug Eluting Implant Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Drug Eluting Implant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Drug Eluting Implant Sales by Country (2019-2024) & (K Units)
Table 32. Europe Drug Eluting Implant Sales by Country (2025-2030) & (K Units)
Table 33. Europe Drug Eluting Implant Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Drug Eluting Implant Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Drug Eluting Implant Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Drug Eluting Implant Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Drug Eluting Implant Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Drug Eluting Implant Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Drug Eluting Implant Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drug Eluting Implant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Drug Eluting Implant Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Drug Eluting Implant Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Drug Eluting Implant Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drug Eluting Implant Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drug Eluting Implant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Drug Eluting Implant Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Drug Eluting Implant Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Drug Eluting Implant Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Drug Eluting Implant Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Drug Eluting Implant Sales (K Units) by Type (2019-2024)
Table 51. Global Drug Eluting Implant Sales (K Units) by Type (2025-2030)
Table 52. Global Drug Eluting Implant Sales Market Share by Type (2019-2024)
Table 53. Global Drug Eluting Implant Sales Market Share by Type (2025-2030)
Table 54. Global Drug Eluting Implant Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Drug Eluting Implant Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Drug Eluting Implant Revenue Market Share by Type (2019-2024)
Table 57. Global Drug Eluting Implant Revenue Market Share by Type (2025-2030)
Table 58. Global Drug Eluting Implant Price (US$/Unit) by Type (2019-2024)
Table 59. Global Drug Eluting Implant Price (US$/Unit) by Type (2025-2030)
Table 60. Global Drug Eluting Implant Sales (K Units) by Application (2019-2024)
Table 61. Global Drug Eluting Implant Sales (K Units) by Application (2025-2030)
Table 62. Global Drug Eluting Implant Sales Market Share by Application (2019-2024)
Table 63. Global Drug Eluting Implant Sales Market Share by Application (2025-2030)
Table 64. Global Drug Eluting Implant Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Drug Eluting Implant Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Drug Eluting Implant Revenue Market Share by Application (2019-2024)
Table 67. Global Drug Eluting Implant Revenue Market Share by Application (2025-2030)
Table 68. Global Drug Eluting Implant Price (US$/Unit) by Application (2019-2024)
Table 69. Global Drug Eluting Implant Price (US$/Unit) by Application (2025-2030)
Table 70. Boston Scientific Corporation Information
Table 71. Boston Scientific Description and Business Overview
Table 72. Boston Scientific Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Boston Scientific Drug Eluting Implant Product
Table 74. Boston Scientific Recent Developments/Updates
Table 75. Medtronic Corporation Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Medtronic Drug Eluting Implant Product
Table 79. Medtronic Recent Developments/Updates
Table 80. Abbott Corporation Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Abbott Drug Eluting Implant Product
Table 84. Abbott Recent Developments/Updates
Table 85. Lepu Medical Corporation Information
Table 86. Lepu Medical Description and Business Overview
Table 87. Lepu Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Lepu Medical Drug Eluting Implant Product
Table 89. Lepu Medical Recent Developments/Updates
Table 90. B. Braun Melsungen Corporation Information
Table 91. B. Braun Melsungen Description and Business Overview
Table 92. B. Braun Melsungen Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. B. Braun Melsungen Drug Eluting Implant Product
Table 94. B. Braun Melsungen Recent Developments/Updates
Table 95. MicroPort Scientific Corporation Information
Table 96. MicroPort Scientific Description and Business Overview
Table 97. MicroPort Scientific Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. MicroPort Scientific Drug Eluting Implant Product
Table 99. MicroPort Scientific Recent Developments/Updates
Table 100. Cook Medical Corporation Information
Table 101. Cook Medical Description and Business Overview
Table 102. Cook Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Cook Medical Drug Eluting Implant Product
Table 104. Cook Medical Recent Developments/Updates
Table 105. Terumo Corporation Information
Table 106. Terumo Description and Business Overview
Table 107. Terumo Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Terumo Drug Eluting Implant Product
Table 109. Terumo Recent Developments/Updates
Table 110. Biosensors International Corporation Information
Table 111. Biosensors International Description and Business Overview
Table 112. Biosensors International Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Biosensors International Drug Eluting Implant Product
Table 114. Biosensors International Recent Developments/Updates
Table 115. Balton Corporation Information
Table 116. Balton Description and Business Overview
Table 117. Balton Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Balton Drug Eluting Implant Product
Table 119. Balton Recent Developments/Updates
Table 120. AlviMedica Medical Technologies Corporation Information
Table 121. AlviMedica Medical Technologies Description and Business Overview
Table 122. AlviMedica Medical Technologies Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. AlviMedica Medical Technologies Drug Eluting Implant Product
Table 124. AlviMedica Medical Technologies Recent Developments/Updates
Table 125. Biotronik Corporation Information
Table 126. Biotronik Description and Business Overview
Table 127. Biotronik Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Biotronik Drug Eluting Implant Product
Table 129. Biotronik Recent Developments/Updates
Table 130. Shandong JW Medical Corporation Information
Table 131. Shandong JW Medical Description and Business Overview
Table 132. Shandong JW Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Shandong JW Medical Drug Eluting Implant Product
Table 134. Shandong JW Medical Recent Developments/Updates
Table 135. Sino Medical Corporation Information
Table 136. Sino Medical Description and Business Overview
Table 137. Sino Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Sino Medical Drug Eluting Implant Product
Table 139. Sino Medical Recent Developments/Updates
Table 140. Beijing AMSINO Corporation Information
Table 141. Beijing AMSINO Description and Business Overview
Table 142. Beijing AMSINO Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Beijing AMSINO Drug Eluting Implant Product
Table 144. Beijing AMSINO Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Drug Eluting Implant Distributors List
Table 148. Drug Eluting Implant Customers List
Table 149. Drug Eluting Implant Market Trends
Table 150. Drug Eluting Implant Market Drivers
Table 151. Drug Eluting Implant Market Challenges
Table 152. Drug Eluting Implant Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug Eluting Implant
Figure 2. Global Drug Eluting Implant Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Drug Eluting Implant Market Share by Type in 2023 & 2030
Figure 4. Rapamycin Eluting Implant Product Picture
Figure 5. Paclitaxel Eluting Implant Product Picture
Figure 6. Everolimus Eluting Implant Product Picture
Figure 7. Others Product Picture
Figure 8. Global Drug Eluting Implant Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Drug Eluting Implant Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Ambulatory Surgical Centers
Figure 13. Others
Figure 14. Global Drug Eluting Implant Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Drug Eluting Implant Market Size (2019-2030) & (US$ Million)
Figure 16. Global Drug Eluting Implant Sales (2019-2030) & (K Units)
Figure 17. Global Drug Eluting Implant Average Price (US$/Unit) & (2019-2030)
Figure 18. Drug Eluting Implant Report Years Considered
Figure 19. Drug Eluting Implant Sales Share by Manufacturers in 2023
Figure 20. Global Drug Eluting Implant Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Drug Eluting Implant Players: Market Share by Revenue in 2023
Figure 22. Drug Eluting Implant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Drug Eluting Implant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Drug Eluting Implant Sales Market Share by Country (2019-2030)
Figure 25. North America Drug Eluting Implant Revenue Market Share by Country (2019-2030)
Figure 26. United States Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Drug Eluting Implant Sales Market Share by Country (2019-2030)
Figure 29. Europe Drug Eluting Implant Revenue Market Share by Country (2019-2030)
Figure 30. Germany Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Drug Eluting Implant Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Drug Eluting Implant Revenue Market Share by Region (2019-2030)
Figure 37. China Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Drug Eluting Implant Sales Market Share by Country (2019-2030)
Figure 47. Latin America Drug Eluting Implant Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Drug Eluting Implant Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Drug Eluting Implant Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Drug Eluting Implant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Drug Eluting Implant by Type (2019-2030)
Figure 57. Global Revenue Market Share of Drug Eluting Implant by Type (2019-2030)
Figure 58. Global Drug Eluting Implant Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Drug Eluting Implant by Application (2019-2030)
Figure 60. Global Revenue Market Share of Drug Eluting Implant by Application (2019-2030)
Figure 61. Global Drug Eluting Implant Price (US$/Unit) by Application (2019-2030)
Figure 62. Drug Eluting Implant Value Chain
Figure 63. Drug Eluting Implant Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock